Johannes Kuehle

1.3k total citations
22 papers, 1.0k citations indexed

About

Johannes Kuehle is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Johannes Kuehle has authored 22 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Genetics and 9 papers in Oncology. Recurrent topics in Johannes Kuehle's work include CRISPR and Genetic Engineering (12 papers), Virus-based gene therapy research (9 papers) and CAR-T cell therapy research (9 papers). Johannes Kuehle is often cited by papers focused on CRISPR and Genetic Engineering (12 papers), Virus-based gene therapy research (9 papers) and CAR-T cell therapy research (9 papers). Johannes Kuehle collaborates with scholars based in Germany, United States and Netherlands. Johannes Kuehle's co-authors include Axel Schambach, Melanie Galla, Juergen Bode, Tobias Maetzig, Hinrich Abken, Soeren Turan, Tobias Cantz, Christopher Baum, Martijn H. Brugman and Christopher Baum and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Biomaterials.

In The Last Decade

Johannes Kuehle

22 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Johannes Kuehle Germany 17 756 403 338 194 119 22 1.0k
Ermira Samara-Kuko Belgium 10 868 1.1× 502 1.2× 198 0.6× 85 0.4× 67 0.6× 13 1.1k
Laura Riolobos Spain 8 503 0.7× 227 0.6× 305 0.9× 158 0.8× 68 0.6× 9 862
Bian Hu China 17 1.1k 1.5× 360 0.9× 389 1.2× 196 1.0× 81 0.7× 30 1.5k
Alessio Cantore Italy 17 1.2k 1.6× 905 2.2× 378 1.1× 159 0.8× 42 0.4× 30 1.7k
Timothy Davis United States 12 768 1.0× 320 0.8× 367 1.1× 146 0.8× 44 0.4× 17 1.1k
Abel Acosta‐Sanchez Belgium 7 882 1.2× 560 1.4× 192 0.6× 152 0.8× 43 0.4× 8 1.2k
Agnès Gouble France 16 904 1.2× 456 1.1× 635 1.9× 160 0.8× 175 1.5× 37 1.3k
Jon P. Connelly United States 15 1.1k 1.5× 369 0.9× 144 0.4× 264 1.4× 28 0.2× 29 1.4k
Yukoh Nakazaki Japan 17 436 0.6× 179 0.4× 350 1.0× 549 2.8× 51 0.4× 30 1.0k
Aric Colunga United States 7 339 0.4× 143 0.4× 334 1.0× 147 0.8× 91 0.8× 7 676

Countries citing papers authored by Johannes Kuehle

Since Specialization
Citations

This map shows the geographic impact of Johannes Kuehle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johannes Kuehle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johannes Kuehle more than expected).

Fields of papers citing papers by Johannes Kuehle

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johannes Kuehle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johannes Kuehle. The network helps show where Johannes Kuehle may publish in the future.

Co-authorship network of co-authors of Johannes Kuehle

This figure shows the co-authorship network connecting the top 25 collaborators of Johannes Kuehle. A scholar is included among the top collaborators of Johannes Kuehle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johannes Kuehle. Johannes Kuehle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altvater, Bianca, Sareetha Kailayangiri, Jutta Meltzer, et al.. (2023). CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process. Cancer Gene Therapy. 30(10). 1355–1368. 13 indexed citations
2.
Hoffmann, Dirk, Sebastian Brennig, Johannes Kuehle, et al.. (2021). Genetic Correction of IL-10RB Deficiency Reconstitutes Anti-Inflammatory Regulation in iPSC-Derived Macrophages. Journal of Personalized Medicine. 11(3). 221–221. 9 indexed citations
3.
Zimmermann, Katharina, Melanie Galla, Johann Meyer, et al.. (2021). Generation of an NFκB-Driven Alpharetroviral “All-in-One” Vector Construct as a Potent Tool for CAR NK Cell Therapy. Frontiers in Immunology. 12. 751138–751138. 17 indexed citations
4.
Hoffmann, Dirk, Johannes Kuehle, Daniela Zychlinski, et al.. (2020). Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells. Gene Therapy. 27(6). 297–306. 10 indexed citations
5.
Alzubi, Jamal, Johannes Kuehle, Maximilian Seidl, et al.. (2020). PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model. Molecular Therapy — Oncolytics. 18. 226–235. 41 indexed citations
6.
Chmielewski, Markus, et al.. (2019). FimH-based display of functional eukaryotic proteins on bacteria surfaces. Scientific Reports. 9(1). 8410–8410. 11 indexed citations
7.
Kuehle, Johannes, et al.. (2018). CD28-ζ CAR T Cells Resist TGF-β Repression through IL-2 Signaling, Which Can Be Mimicked by an Engineered IL-7 Autocrine Loop. Molecular Therapy. 26(9). 2218–2230. 76 indexed citations
8.
Geis, Franziska K., Dirk Heckl, Stefan Horn, et al.. (2018). Transient Retrovirus-Based CRISPR/Cas9 All-in-One Particles for Efficient, Targeted Gene Knockout. Molecular Therapy — Nucleic Acids. 13. 256–274. 43 indexed citations
9.
Kuehle, Johannes, et al.. (2017). Genetic Modification of T Cells with Chimeric Antigen Receptors: A Laboratory Manual. Human Gene Therapy Methods. 28(6). 302–309. 16 indexed citations
10.
Geis, Franziska K., Melanie Galla, Dirk Hoffmann, et al.. (2017). Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells. Retrovirology. 14(1). 34–34. 16 indexed citations
11.
Kuehle, Johannes, Christian Reimann, Jamal Alzubi, et al.. (2015). Rescue of DNA-PK Signaling and T-Cell Differentiation by Targeted Genome Editing in a prkdc Deficient iPSC Disease Model. PLoS Genetics. 11(5). e1005239–e1005239. 9 indexed citations
12.
Kuehle, Johannes, Soeren Turan, Tobias Cantz, et al.. (2014). Modified Lentiviral LTRs Allow Flp Recombinase–mediated Cassette Exchange and In Vivo Tracing of “Factor-free” Induced Pluripotent Stem Cells. Molecular Therapy. 22(5). 919–928. 20 indexed citations
13.
Maetzig, Tobias, Johannes Kuehle, Adrian Schwarzer, et al.. (2014). All-in-One inducible lentiviral vector systems based on drug controlled FLP recombinase. Biomaterials. 35(14). 4345–4356. 20 indexed citations
14.
Bobis‐Wozowicz, Sylwia, Melanie Galla, Jamal Alzubi, et al.. (2014). Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery. Scientific Reports. 4(1). 4656–4656. 23 indexed citations
15.
Turan, Soeren, Christoph Zehe, Johannes Kuehle, Junhua Qiao, & Juergen Bode. (2012). Recombinase-mediated cassette exchange (RMCE) — A rapidly-expanding toolbox for targeted genomic modifications. Gene. 515(1). 1–27. 116 indexed citations
16.
Galla, Melanie, Axel Schambach, Christine S. Falk, et al.. (2012). Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Research. 40(2). 939–939. 47 indexed citations
17.
Kuehle, Johannes, Tobias Cantz, Martijn H. Brugman, et al.. (2011). Lentiviral Vector Design and Imaging Approaches to Visualize the Early Stages of Cellular Reprogramming. Molecular Therapy. 19(4). 782–789. 206 indexed citations
18.
Galla, Melanie, Axel Schambach, Christine S. Falk, et al.. (2011). Avoiding cytotoxicity of transposases by dose-controlled mRNA delivery. Nucleic Acids Research. 39(16). 7147–7160. 53 indexed citations
19.
Turan, Soeren, Johannes Kuehle, Axel Schambach, Christopher Baum, & Juergen Bode. (2010). Multiplexing RMCE: Versatile Extensions of the Flp-Recombinase-Mediated Cassette-Exchange Technology. Journal of Molecular Biology. 402(1). 52–69. 57 indexed citations
20.
Galla, Melanie, Tobias Maetzig, Johannes Kuehle, et al.. (2010). Protein transduction from retroviral Gag precursors. Proceedings of the National Academy of Sciences. 107(17). 7805–7810. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ermira Samara-Kuko Breakdown of academic impact, for papers by Laura Riolobos Breakdown of academic impact, for papers by Bian Hu Breakdown of academic impact, for papers by Alessio Cantore Breakdown of academic impact, for papers by Timothy Davis Breakdown of academic impact, for papers by Abel Acosta‐Sanchez Breakdown of academic impact, for papers by Agnès Gouble Breakdown of academic impact, for papers by Jon P. Connelly Breakdown of academic impact, for papers by Yukoh Nakazaki Breakdown of academic impact, for papers by Aric Colunga
Rankless by CCL
2026